Case Report: Identifying and Quantifying Medication Errors: Evaluation of Rapidly Discontinued Medication Orders Submitted to a Computerized Physician Order Entry System

All methods of identifying medication prescribing errors are fraught with inaccuracies and systematic bias. A systematic, efficient, and inexpensive way of measuring and quantifying prescribing errors would be a useful step for reducing them. We ask if rapid discontinuations of prescription-orders--where physicians stop their orders within 2 hours--would be an expedient proxy for prescribing errors? To study this we analyzed CPOE-system medication orders entered and then discontinued within 2 hours. We investigated these phenomena in real time via interviews with corresponding ordering physicians. Each order was also independently reviewed by a clinical pharmacist or physicians. We found that of 114 rapidly discontinued orders by 75 physicians, two-thirds (35 of 53, PPV = 66; 95% CI = 53-77) of medication orders discontinued within 45 minutes were deemed inappropriate (overdose, underdose, etc.). Overall, 55% (63 of 114; 95% CI = 46-64%) of medication orders discontinued within 2 hours were deemed inappropriate. This measure offers a rapid, constant, inexpensive, and objective method to identify medication orders with a high probability of error. It may also serve as a screening and teaching mechanism for physicians-in-training.

[1]  D. Bates,et al.  Adverse drug events and medication errors: detection and classification methods , 2004, Quality and Safety in Health Care.

[2]  L. Kohn,et al.  To Err Is Human : Building a Safer Health System , 2007 .

[3]  S D Small,et al.  The incident reporting system does not detect adverse drug events: a problem for quality improvement. , 1995, The Joint Commission journal on quality improvement.

[4]  A. Localio,et al.  Role of computerized physician order entry systems in facilitating medication errors. , 2005, JAMA.

[5]  J. McCulloch,et al.  CHAPTER 7 – Implications for Prevention , 1972 .

[6]  Albert W Wu,et al.  ICU incident reporting systems. , 2002, Journal of critical care.

[7]  S D Small,et al.  Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. , 1995, JAMA.

[8]  D. Bates,et al.  Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. , 1999, JAMA.

[9]  J C Russo,et al.  Medication error prevention by clinical pharmacists in two children's hospitals. , 1987, Pediatrics.

[10]  D S Stein,et al.  Factors related to errors in medication prescribing. , 1997, JAMA.

[11]  D. Bates,et al.  Systems analysis of adverse drug events. ADE Prevention Study Group. , 1995, JAMA.

[12]  D. Coplen Types of Unintended Consequences Related to Computerized Provider Order Entry , 2007 .

[13]  S. R. Abel,et al.  Medication error prevention by pharmacists. , 1988, American journal of hospital pharmacy.

[14]  Marvin C. Alkin,et al.  What Have We Learned? , 2019, Stumbling Blocks Against Unification.

[15]  P. Shekelle,et al.  Systematic Review: Impact of Health Information Technology on Quality, Efficiency, and Costs of Medical Care , 2006, Annals of Internal Medicine.

[16]  A. Wall,et al.  Book ReviewTo Err is Human: building a safer health system Kohn L T Corrigan J M Donaldson M S Washington DC USA: Institute of Medicine/National Academy Press ISBN 0 309 06837 1 $34.95 , 2000 .

[17]  David W Bates,et al.  Medication errors observed in 36 health care facilities. , 2002, Archives of internal medicine.

[18]  David W. Bates,et al.  Systems Analysis of Adverse Drug Events , 2008 .

[19]  J. P. Kichak,et al.  Computerized physician order entry: helpful or harmful? , 2003, Journal of the American Medical Informatics Association : JAMIA.

[20]  N. Dickey,et al.  Systems analysis of adverse drug events. , 1996, JAMA.

[21]  Thomas H. Payne,et al.  Review Paper: Medication-related Clinical Decision Support in Computerized Provider Order Entry Systems: A Review , 2007, J. Am. Medical Informatics Assoc..

[22]  Craig Senholzi,et al.  Pharmacist interventions after implementation of computerized prescriber order entry. , 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[23]  J. Feinglass,et al.  The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. , 2004, Archives of internal medicine.

[24]  Subashan Perera,et al.  Research Paper: A Systematic Review of the Performance Characteristics of Clinical Event Monitor Signals Used to Detect Adverse Drug Events in the Hospital Setting , 2007, J. Am. Medical Informatics Assoc..

[25]  Ross Koppel,et al.  Defending computerized physician order entry from its supporters. , 2006, The American journal of managed care.

[26]  D. Bates,et al.  Improving safety with information technology. , 2003, The New England journal of medicine.

[27]  M Berg,et al.  Same Systems, Different Outcomes , 2006, Methods of Information in Medicine.

[28]  D. Bates,et al.  Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. , 2003, Archives of internal medicine.

[29]  R S Evans,et al.  Description of a computerized adverse drug event monitor using a hospital information system. , 1992, Hospital pharmacy.

[30]  Marc Berg,et al.  Extending the understanding of computerized physician order entry: Implications for professional collaboration, workflow and quality of care , 2007, Int. J. Medical Informatics.

[31]  Paul N. Gorman,et al.  Computerized physician order entry in U.S. hospitals: results of a 2002 survey. , 2003, Journal of the American Medical Informatics Association : JAMIA.

[32]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[33]  R. Resar,et al.  Adverse drug event trigger tool: a practical methodology for measuring medication related harm , 2003, Quality & safety in health care.

[34]  N. Laird,et al.  Incidence of adverse drug events and potential adverse drug events , 1995 .